Ophthalmology Ai Platform

LumineticsCore is an Al diagnostic system that independently diagnoses diabetic retinopathy (including macular edema) in the diabetic population.Diagnostic outcomes at the point of care

There is no requirement for specialist overreads or telemedicine call backs.

A user interface that is straightforwardWorkflow integration solutions that are tailored to your specificinput:
output:The Issue: Diabetic retinopathy causes the blindness of more than 60,000 individuals annually.

The Operation of LumineticsCore
One The operator is trained to capture two images per eye using a fundus camera.

Two The images are submitted to LumineticsCore.3 LumineticsCore analyzes images for signs of diabetic retinopathy, including macular edema, and provides results in less than a minute.Results br/>

Diabetic retinopathy was not identified: Results in 12 months br/>

RetestDiabetic retinopathy was identified: Consult with an eye care professional.Our Methodology for AI-Driven DiagnosticsAI in the Correct Manner™LumineticsCore™ is designed to identify and make decisions using the same clinical disease detectors that eye care specialists would employ.input:
output:Diagnostic artificial intelligence that is founded on ethical principles

Results of diagnostic tests administered at the point of care

Infinitely expandableinput:
output:High Performance in a Real-World Clinical Environmentinput:
output:Security

In order to maintain patient safety as the primary concern, LumineticsCore was validated against patient outcomes using a surrogate outcome standard.Effective

By delivering a diagnostic result that was negative for diabetic retinopathy (including macular edema) at the point of care, LumineticsCore prevented 91% of unnecessary specialty visits in our pivotal clinical trial.